In the last trading session, 5.38 million shares of the Biodesix Inc (NASDAQ:BDSX) were traded, and its beta was 1.11. Most recently the company’s share price was $0.72, and it changed around $0.01 or 0.98% from the last close, which brings the market valuation of the company to $104.74M. BDSX currently trades at a discount to its 52-week high of $2.04, offering almost -183.33% off that amount. The share price’s 52-week low was $0.70, which indicates that the current value has risen by an impressive 2.78% since then.
Biodesix Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended BDSX as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. Biodesix Inc is expected to report earnings per share of 0 for the current quarter.
Biodesix Inc (NASDAQ:BDSX) trade information
Instantly BDSX has showed a green trend with a performance of 0.98% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.8800 on recent trading dayincreased the stock’s daily price by 18.18%. The company’s shares are currently down -52.94% year-to-date, but still down -10.07% over the last five days. On the other hand, Biodesix Inc (NASDAQ:BDSX) is -30.10% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $3, which translates to bulls needing to increase their stock price by 76.0% from its current value. Analyst projections state that BDSX is forecast to be at a low of $3 and a high of $3.
Biodesix Inc (BDSX) estimates and forecasts
The year-over-year growth rate is expected to be 30.35%, up from the previous year.
Consensus estimates provided by 6 financial analysts predict the company will bring in an average of 19.5M in revenue for the current quarter. 6 analysts expect Biodesix Inc to make 22.57M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 14.82M and 17.93M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 31.60%. Forecasts for the next quarter put sales growth at 25.89%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 69.26%. Biodesix Inc earnings are expected to increase by 37.37% in 2025, but the outlook is positive 38.97% per year for the next five years.
BDSX Dividends
Biodesix Inc’s next quarterly earnings report is expected to be released in April.
SOLEUS CAPITAL MANAGEMENT, L.P., with 4.8062% or 6.11 million shares worth $9.35 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 1.44 shares worth $1.03 million, making up 0.99% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 1.42 shares worth around $1.02 million, which represents about 0.98% of the total shares outstanding.
